V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002150 | 250004366 | 1.74 | 101.9 | null | null | 2018-02-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + FLUOROURACIL | 101427525 |
| 250002153 | 250004367 | 1.6 | 59.2 | null | 2019-12-07 | 2019-12-10 | null | 02 | Y | SUNITINIB | 100292841 |
| 250002154 | 250004368 | 1.82 | 70 | Palliative (P) | 2016-12-26 | 2017-01-01 | ICON8B TRIAL | 02 | null | DOCETAXEL | 100338236 |
| 250002156 | 250004370 | null | null | null | 2017-05-01 | 2017-05-29 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | CISPLATIN + FLUOROURACIL | 100604334 |
| 250002159 | 250004372 | 1.78 | 24.7 | Palliative (P) | null | 2018-03-16 | Trial Unspecified | N | null | CAPECITABINE + CARBOPLATIN | 101834052 |
| 250002161 | 250004374 | null | 125.9 | null | null | 2019-08-17 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100250505 |
| 250002163 | 250004376 | 1.57 | 80.2 | Palliative (P) | 2018-10-25 | 2019-01-02 | CAPMATINIB | 02 | Y | CISPLATIN + FLUOROURACIL | 101357085 |
| 250002170 | 250004381 | 1.79 | 106 | Neo-adjuvant (N) | 2018-08-04 | 2018-08-13 | Cisplatin 7 day | 02 | null | IMATINIB | 100612166 |
| 250002171 | 250004382 | null | null | null | 2019-05-02 | 2019-05-03 | Atezolizumab | 02 | N | GEMCITABINE | 100840939 |
| 250002172 | 250004383 | 1.83 | 86 | Palliative (P) | 2019-06-23 | 2019-06-24 | null | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 101483986 |
| 250002176 | 250004384 | null | null | Palliative (P) | null | 2019-07-26 | Carboplatin + Liposomal Doxorubicin | null | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101313112 |
| 250002177 | 250004385 | 1.79 | 85.1 | Palliative (P) | 2020-10-14 | 2020-10-22 | NB HRNBL-1 Isotretinoin | 02 | null | CARBOPLATIN + ETOPOSIDE | 100512158 |
| 250002189 | 250004392 | 1.71 | 53 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-05 | Doxorubicin 75mg/m2 | 2 | N | DOXORUBICIN | 100959745 |
| 250002194 | 250004394 | 1.62 | 87.5 | null | 2019-08-16 | 2019-08-27 | Atezolizumab | 02 | N | PACLITAXEL | 100325175 |
| 250002195 | 250004395 | 1.8 | 65 | null | null | 2020-05-01 | Sunitinib | null | null | CAPECITABINE + OXALIPLATIN | 100277141 |
| 250002196 | 250004396 | 1.75 | 88.9 | Palliative (P) | 2018-06-30 | 2018-07-10 | CARBOPLATIN + PACLITAXEL | 02 | null | IPILIMUMAB + NIVOLUMAB | 101285405 |
| 250002198 | 250004398 | 1.83 | 74.1 | null | 2018-06-29 | 2018-06-29 | Sunitinib | 2 | N | CISPLATIN + ETOPOSIDE | 101170169 |
| 250002200 | 250004400 | null | null | null | null | 2020-02-10 | CAPECITABINE + CARBOPLATIN | null | Y | TRIAL UNSPECIFIED | 100682583 |
| 250002206 | 250004406 | 1.64 | 13.6 | Palliative (P) | 2016-06-08 | 2016-06-29 | NB HRNBL-1 ch14.18/CHO only (trial) | 01 | null | DOCETAXEL + GEMCITABINE | 101098201 |
| 250002219 | 250004417 | 1.66 | 9.9 | Palliative (P) | null | 2019-09-16 | null | null | N | PAZOPANIB | 100907103 |
| 250002220 | 250004418 | 1.75 | 4.3 | Curative (C) | 2019-07-19 | 2019-08-27 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | CISPLATIN + FLUOROURACIL | 101378460 |
| 250002225 | 250004421 | null | null | null | 2017-02-02 | 2017-02-06 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101467281 |
| 250002227 | 250004422 | null | null | Palliative (P) | 2019-01-28 | 2019-02-05 | Dinutuximab Beta | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 100248687 |
| 250002230 | 250004424 | 1.83 | 70.3 | Curative (C) | 2016-10-15 | 2016-10-18 | Sunitinib | 02 | N | DOXORUBICIN + OLARATUMAB | 100166680 |
| 250002234 | 250004426 | 0 | 66.7 | null | null | 2018-04-26 | NB BEACON Dinutuximab, Temozolomide and Topotecan | 01 | N | CAPECITABINE + OXALIPLATIN | 101705633 |
| 250002237 | 250004428 | 1.78 | 60.15 | Neo-adjuvant (N) | 2019-03-23 | 2019-04-13 | null | 02 | N | VAI | 100773104 |
| 250002240 | 250004431 | 1.61 | 98 | null | 2016-07-17 | 2017-04-30 | Sunitinib | 02 | N | DOXORUBICIN | 100812506 |
| 250002242 | 250004433 | null | null | 03 | 2018-01-12 | 2018-01-19 | CARBOPLATIN + RT | 02 | null | CAPECITABINE + OXALIPLATIN | 101334380 |
| 250002245 | 250004436 | 1.71 | 40 | Palliative (P) | 2016-06-28 | 2016-08-17 | null | 02 | N | ENZALUTAMIDE | 100936287 |
| 250002246 | 250004437 | null | null | Palliative (P) | null | null | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | DOCETAXEL + GEMCITABINE | 100136221 |
| 250002249 | 250004439 | 1.85 | 71.7 | null | null | 2019-04-22 | null | 01 | N | IPILIMUMAB + NIVOLUMAB | 100640187 |
| 250002252 | 250004441 | 1.75 | 105.7 | Palliative (P) | 2019-09-19 | 2019-10-03 | BCG Intravesical | 02 | null | PAZOPANIB | 101497749 |
| 250002254 | 250004442 | 1.87 | 12 | null | 2020-03-29 | 2020-04-10 | Lomustine | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100575057 |
| 250002258 | 250004446 | null | null | null | 2018-10-04 | 2019-02-07 | Carboplatin + Pemetrexed | 02 | null | BEVACIZUMAB | 101171265 |
| 250002263 | 250004450 | 1.56 | 69 | Palliative (P) | 2017-10-27 | 2017-10-28 | Vinorelbine (oral) | 02 | null | CARBOPLATIN + FLUOROURACIL | 100975579 |
| 250002265 | 250004451 | null | null | null | null | 2018-04-13 | PACLITAXEL | null | null | DOXORUBICIN + IFOSFAMIDE | 101410943 |
| 250002266 | 250004452 | 1.85 | 73.6 | Palliative (P) | 2017-09-09 | 2017-09-10 | null | Y | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100799075 |
| 250002267 | 250004453 | 1.66 | 54.9 | null | 2018-03-17 | 2018-03-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + PEMETREXED | 101699567 |
| 250002270 | 250004455 | null | null | null | null | 2016-11-04 | null | null | null | CARBOPLATIN + PACLITAXEL | 100469364 |
| 250002280 | 250004461 | null | null | Palliative (P) | 2016-09-03 | 2016-10-11 | IVADo | 02 | null | CAPECITABINE + CARBOPLATIN | 100171267 |
| 250002286 | 250004467 | 1.82 | 86.9 | Palliative (P) | null | 2018-06-04 | FLUOROURACIL + IRINOTECAN | 02 | N | PACLITAXEL | 100551826 |
| 250002292 | 250004470 | 1.67 | 105.9 | Palliative (P) | 2017-07-28 | 2017-08-08 | Sunitinib | 02 | N | DOXORUBICIN | 101447840 |
| 250002294 | 250004472 | 1.6 | 74 | Palliative (P) | 2018-05-31 | 2018-05-31 | null | 02 | N | OSIMERTINIB | 101014106 |
| 250002296 | 250004474 | 1.73 | 67.3 | Curative (C) | 2018-07-26 | 2018-09-13 | EW Rel rEECur Ifosfamide | 02 | N | DOXORUBICIN + OLARATUMAB | 101098439 |
| 250002300 | 250004476 | null | 0 | Palliative (P) | 2018-09-02 | 2018-09-06 | Trial Unspecified | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 101099482 |
| 250002302 | 250004477 | null | null | null | null | 2020-03-25 | EVEROLIMUS | null | Y | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100341985 |
| 250002303 | 250004478 | 1.76 | 59 | Palliative (P) | 2019-01-28 | 2019-02-03 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100982714 |
| 250002306 | 250004481 | 1.79 | 69 | Palliative (P) | 2018-09-25 | 2018-10-04 | VINORELBINE | 02 | Y | CISPLATIN + FLUOROURACIL | 101569819 |
| 250002310 | 250004485 | 1.68 | 75 | null | 2018-07-13 | 2018-07-13 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 100066307 |
| 250002311 | 250004486 | 1.76 | 53.9 | null | 2020-12-13 | 2022-03-31 | CISPLATIN + FLUOROURACIL | 02 | N | ENZALUTAMIDE | 101794766 |